| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0161-6420(99)90496-7 |
| P698 | PubMed publication ID | 10571350 |
| P2093 | author name string | Ahmed AR | |
| Foster CS | |||
| P2860 | cites work | Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid | Q28246254 |
| Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood | Q33442866 | ||
| Pathology of practolol-induced ocular toxicity | Q33649679 | ||
| Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization | Q36837479 | ||
| Benign mucous membrane pemphigoid. Response to therapy with cyclophosphamide | Q40835374 | ||
| Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro | Q41516882 | ||
| Preliminary serological studies comparing immunofluorescence assay with radioimmunoassay | Q43751210 | ||
| Induced ocular pseudopemphigoid | Q67487055 | ||
| High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis | Q67569073 | ||
| Treatment of myasthenia gravis with high-dose intravenous immunoglobulin | Q68057302 | ||
| Azathioprine in the treatment of muco-cutaneous pemphigoid | Q69745805 | ||
| Systemic chemotherapy for ocular cicatricial pemphigoid | Q70198195 | ||
| Immunosuppressive therapy for progressive ocular cicatricial pemphigoid | Q70249115 | ||
| Idoxuridine-Induced Conjunctival Cicatrization | Q70254965 | ||
| Immunosuppressive Therapy in Ocular Cicatricial Pemphigoid | Q70287560 | ||
| Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain | Q70978926 | ||
| Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid | Q71161048 | ||
| Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines | Q72562056 | ||
| P433 | issue | 11 | |
| P921 | main subject | cicatricial pemphigoid | Q627291 |
| P304 | page(s) | 2136-2143 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Ophthalmology | Q7098109 |
| P1476 | title | Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. | |
| P478 | volume | 106 |
| Q38250103 | A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II. |
| Q34615160 | Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management |
| Q35164653 | Autoimmune bullous dermatoses in the elderly: diagnosis and management |
| Q36237529 | Autoimmune bullous diseases: ocular manifestations and management |
| Q28205009 | Blistering disorders: diagnosis and treatment |
| Q36711702 | Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology |
| Q45592824 | Cicatricial pemphigoid, mucous membrane pemphigoid |
| Q38364539 | Clinical outcomes of intravenous immunoglobulin therapy in refractory uveitis |
| Q41881207 | Combination treatment of intravenous immunoglobulin and cultivated oral mucosal epithelial transplantation for ocular cicatricial pemphigoid |
| Q42840844 | Combination treatment of intravenous immunoglobulin and cultivated oral mucosal epithelial transplantation for ocular cicatricial pemphigoid |
| Q50771840 | Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study. |
| Q45283556 | Desquamative gingivitis associated with IgG/IgA pemphigoid presents a challenging diagnosis and treatment: a case report |
| Q28348355 | Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses |
| Q36018288 | Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience |
| Q45722797 | Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita |
| Q36794149 | Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders |
| Q34436707 | Eye involvement in autoimmune blistering diseases |
| Q37532013 | High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases |
| Q74666083 | High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders |
| Q73086648 | IVIG as a nonspecific accelerator of restitutio ad integrum |
| Q34473549 | IVIG-pools: regulatory gifts--transiting from harmony toward harmonious immunoglobulins: why? and why not? |
| Q24250186 | Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita |
| Q37933423 | Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update |
| Q36177681 | Mucosal disease series. Number III. Mucous membrane pemphigoid |
| Q77161223 | Mucous membrane pemphigoid |
| Q44598798 | Mycophenolatmofetil als effektive Therapieoption bei vernarbendem Pemphigoid |
| Q34436463 | New immunomodulating drugs in autoimmune blistering diseases |
| Q74182580 | Node way out |
| Q64095262 | Ocular Manifestations and Management of Autoimmune Bullous Diseases |
| Q37940584 | Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management |
| Q36168693 | Ocular cicatricial pemphigoid: manifestations and management |
| Q39367693 | Outcomes of cataract surgery in ocular cicatricial pemphigoid |
| Q33737974 | Shifting Focus in the Therapeutics of Immunobullous Disease |
| Q43683337 | Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: molecular characterization of both autoantibodies |
| Q43842999 | The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid |
| Q28067526 | The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature |
| Q36986054 | The use of i.v. IG therapy in dermatology |
| Q35919150 | Therapy of autoimmune bullous diseases |
| Q35842548 | Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy |
| Q42525239 | Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin |
| Q34436725 | Treatment of subepidermal immunobullous diseases |
| Q41359384 | Treatment strategies in mucous membrane pemphigoid |
| Q38169809 | Urban legend series: mucous membrane pemphigoid |
| Q82543333 | [Mucous membrane pemphigoid: clinical manifestations and treatment with corticosteroids, dapsone and cyclophosphamide in 5 patients] |
Search more.